Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acids Res ; 38(Database issue): D361-5, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19906735

ABSTRACT

The microbial genome database (MBGD) for comparative analysis is a platform for microbial comparative genomics based on automated ortholog group identification. A prominent feature of MBGD is that it allows users to create ortholog groups using a specified subgroup of organisms. The database is constantly updated and now contains almost 1000 genomes. To utilize the MBGD database as a comprehensive resource for investigating microbial genome diversity, we have developed the following advanced functionalities: (i) enhanced assignment of functional annotation, including external database links to each orthologous group, (ii) interface for choosing a set of genomes to compare based on phenotypic properties, (iii) the addition of more eukaryotic microbial genomes (fungi and protists) and some higher eukaryotes as references and (iv) enhancement of the MyMBGD mode, which allows users to add their own genomes to MBGD and now accepts raw genomic sequences without any annotation (in such a case, it runs a gene-finding procedure before identifying the orthologs). Some analysis functions, such as the function to find orthologs with similar phylogenetic patterns, have also been improved. MBGD is accessible at http://mbgd.genome.ad.jp/.


Subject(s)
Computational Biology/methods , Databases, Genetic , Databases, Nucleic Acid , Animals , Computational Biology/trends , Databases, Protein , Genome, Bacterial , Genome, Fungal , Genomics , Humans , Information Storage and Retrieval/methods , Internet , Phylogeny , Protein Structure, Tertiary , Sequence Alignment , Software
3.
BMC Bioinformatics ; 7: 472, 2006 Oct 24.
Article in English | MEDLINE | ID: mdl-17062155

ABSTRACT

BACKGROUND: The recent accumulation of closely related genomic sequences provides a valuable resource for the elucidation of the evolutionary histories of various organisms. However, although numerous alignment calculation and visualization tools have been developed to date, the analysis of complex genomic changes, such as large insertions, deletions, inversions, translocations and duplications, still presents certain difficulties. RESULTS: We have developed a comparative genome analysis tool, named CGAT, which allows detailed comparisons of closely related bacteria-sized genomes mainly through visualizing middle-to-large-scale changes to infer underlying mechanisms. CGAT displays precomputed pairwise genome alignments on both dotplot and alignment viewers with scrolling and zooming functions, and allows users to move along the pre-identified orthologous alignments. Users can place several types of information on this alignment, such as the presence of tandem repeats or interspersed repetitive sequences and changes in G+C contents or codon usage bias, thereby facilitating the interpretation of the observed genomic changes. In addition to displaying precomputed alignments, the viewer can dynamically calculate the alignments between specified regions; this feature is especially useful for examining the alignment boundaries, as these boundaries are often obscure and can vary between programs. Besides the alignment browser functionalities, CGAT also contains an alignment data construction module, which contains various procedures that are commonly used for pre- and post-processing for large-scale alignment calculation, such as the split-and-merge protocol for calculating long alignments, chaining adjacent alignments, and ortholog identification. Indeed, CGAT provides a general framework for the calculation of genome-scale alignments using various existing programs as alignment engines, which allows users to compare the outputs of different alignment programs. Earlier versions of this program have been used successfully in our research to infer the evolutionary history of apparently complex genome changes between closely related eubacteria and archaea. CONCLUSION: CGAT is a practical tool for analyzing complex genomic changes between closely related genomes using existing alignment programs and other sequence analysis tools combined with extensive manual inspection.


Subject(s)
DNA, Bacterial/analysis , Evolution, Molecular , Helicobacter pylori/genetics , Sequence Alignment , Sequence Analysis, DNA/methods , Software , Algorithms , Bacillus subtilis/genetics , Base Composition , Computer Graphics , Conserved Sequence , Databases, Nucleic Acid , Escherichia coli/genetics , Polymorphism, Genetic , Repetitive Sequences, Nucleic Acid/genetics , Reproducibility of Results , Salmonella enterica/genetics
4.
Mol Cell Biol ; 24(17): 7456-68, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15314156

ABSTRACT

A cDNA encoding a novel mucin protein, MUC20, was isolated as a gene that is up-regulated in the renal tissues of patients with immunoglobulin A nephropathy. We demonstrate here that the C terminus of MUC20 associates with the multifunctional docking site of Met without ligand activation, preventing Grb2 recruitment to Met and thus attenuating hepatocyte growth factor (HGF)-induced transient extracellular signal-regulated kinase-1 and -2 activation. Production of MUC20 reduced HGF-induced matrix metalloproteinase expression and proliferation, which require the Grb2-Ras pathway, whereas cell scattering, branching morphogenesis, and survival via the Gab1/phosphatidylinositol 3-kinase (PI3K) pathways was not affected. Thus, MUC20 reduces HGF-induced activation of the Grb2-Ras pathway but not the Gab1/PI3K pathways. We further demonstrate that the cytoplasmic domain of MUC20 has the ability to oligomerize and that the oligomerization augments its affinity for Met. Taken together, these results suggest that MUC20 is a novel regulator of the Met signaling cascade which has a role in suppression of the Grb2-Ras pathway.


Subject(s)
Adaptor Proteins, Signal Transducing , Hepatocyte Growth Factor/metabolism , Mucins/metabolism , Proteins/metabolism , Proto-Oncogene Proteins c-met/metabolism , Signal Transduction/physiology , ras Proteins/metabolism , Amino Acid Sequence , Animals , Binding Sites , Cells, Cultured , Enzyme Activation , Female , GRB2 Adaptor Protein , Humans , Kidney/cytology , Kidney/metabolism , Kidney/pathology , Male , Mice , Mice, Transgenic , Mitogen-Activated Protein Kinases/metabolism , Models, Molecular , Molecular Sequence Data , Mucins/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphoproteins/metabolism , Protein Binding , Proto-Oncogene Proteins c-met/genetics , Sequence Alignment , Two-Hybrid System Techniques
5.
Biochem Biophys Res Commun ; 318(1): 46-52, 2004 May 21.
Article in English | MEDLINE | ID: mdl-15110751

ABSTRACT

We report here that the transcriptional activity of NF-kappaB is negatively regulated by protein disulfide isomerase (PDI). Over-expression of PDI in RAW 264.7 cells strongly suppressed the LPS-induced production of inflammatory cytokines as well as NF-kappaB-dependent luciferase activity. This negative regulation of NF-kappaB was reversed by bacitracin, a PDI inhibitor. Interestingly, NF-kappaB/DNA complex formation and phosphorylation of NF-kappaB subunits was intact in PDI-expressing cells following stimulation with LPS. In addition, PDI and another redox regulator, thioredoxin (TRX), had opposite effects on NF-kappaB-dependent gene expression: activation of the NF-kappaB pathway by TRX was suppressed by expression of PDI in a dose-dependent manner. Finally, PDI expression was induced by the anti-inflammatory cytokine IL-10, and IL-10-mediated inhibition of LPS-induced IL-6 expression was reduced by bacitracin. These findings clearly demonstrate that PDI is a negative regulator of NF-kappaB, and may act downstream of IL-10 in this signaling pathway.


Subject(s)
NF-kappa B/antagonists & inhibitors , Protein Disulfide-Isomerases/physiology , Transcription, Genetic/drug effects , Animals , Bacitracin/pharmacology , Cell Line , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Enzyme Inhibitors/pharmacology , Gene Expression/drug effects , Humans , Interleukin-10/metabolism , Interleukin-6/biosynthesis , Lipopolysaccharides/antagonists & inhibitors , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Mice , NF-kappa B/biosynthesis , NF-kappa B/genetics , Phosphorylation , Protein Disulfide-Isomerases/antagonists & inhibitors , Protein Disulfide-Isomerases/biosynthesis , Protein Disulfide-Isomerases/genetics , RNA, Messenger/biosynthesis , Thioredoxins/antagonists & inhibitors , Thioredoxins/genetics , Thioredoxins/pharmacology , Transcriptional Activation/drug effects , Transfection
6.
J Biol Chem ; 279(3): 1968-79, 2004 Jan 16.
Article in English | MEDLINE | ID: mdl-14565953

ABSTRACT

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis in the world. Here, we identify a cDNA encoding a novel mucin protein, shown previously to be up-regulated in IgAN patients, from a human kidney cDNA library. This protein contains a mucin tandem repeat of 19 amino acids consisting of many threonine, serine, and proline residues and likely to be extensively O-glycosylated; thus, this gene was classified in the mucin family and named MUC20. The human MUC20 gene contains at least four exons and is localized close to MUC4 on chromosome 3q29. We found variations in repeat numbers in the mucin tandem domain, suggesting polymorphism of this region. Northern blot and reverse transcription-PCR analyses revealed that human MUC20 mRNA was expressed most highly in kidney and moderately in placenta, colon, lung, prostate, and liver. Immunohistochemical analysis of human kidney revealed that MUC20 protein was localized in the proximal tubules. Immunoblotting analysis of MUC20 proteins produced in Madin-Darby canine kidney and HEK293 cells indicated the localization of MUC20 protein in a membrane fraction and extensive posttranslational modification. Immunoelectron microscopy of MUC20-producing Madin-Darby canine kidney cells demonstrated that MUC20 protein was localized on the plasma membrane. Expression of MUC20 mRNA in a human kidney cell line was up-regulated by tumor necrosis factor-alpha, phorbol 12-myristate 13-acetate, or lipopolysaccharide. Two species of MUC20 mRNA (hMUC20-L and hMUC20-S), resulting from alternative transcription, were identified in human tissue, whereas only one variant was observed in mouse tissues. Mouse MUC20 mRNA was expressed in the epithelial cells of proximal tubules, and the expression increased dramatically with the progression of lupus nephritis in the kidney of MRL/MpJ-lpr/lpr mice. Moreover, the expression of mouse MUC20 was augmented in renal tissues acutely injured by cisplatin or unilateral ureteral obstruction. These characteristics suggest that the production of MUC20 is correlated with development and progression of IgAN and other renal injuries.


Subject(s)
Kidney Diseases/metabolism , Kidney/metabolism , Mucins/genetics , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Female , Genetic Structures , Glomerulonephritis, IGA/metabolism , Humans , Lupus Nephritis/metabolism , Mice , Mice, Inbred C57BL , Mice, Inbred MRL lpr , Molecular Sequence Data , Mucins/analysis , Mucins/biosynthesis , Polymorphism, Genetic , Transcription, Genetic , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...